Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis.
Saved in:
| Title: | Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis. |
|---|---|
| Authors: | Babu, Suma1 (AUTHOR) sbabu@mgh.harvard.edu, Macklin, Eric A.2 (AUTHOR), Jackson, Katherine E.3 (AUTHOR), Simpson, Elizabeth4 (AUTHOR), Mahoney, Katy1 (AUTHOR), Yu, Hong1 (AUTHOR), Walker, Jason1 (AUTHOR), Simmons, Zachary5 (AUTHOR), David, William S.1 (AUTHOR), Barkhaus, Paul E.6 (AUTHOR), Simionescu, Laura7 (AUTHOR), Dimachkie, Mazen M.8 (AUTHOR), Pestronk, Alan9 (AUTHOR), Salameh, Johnny S.10 (AUTHOR), Weiss, Michael D.11 (AUTHOR), Brooks, Benjamin Rix12 (AUTHOR), Schoenfeld, David2 (AUTHOR), Shefner, Jeremy13 (AUTHOR), Aggarwal, Swati1 (AUTHOR), Cudkowicz, Merit E.1 (AUTHOR) |
| Source: | Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. Feb2020, Vol. 21 Issue 1/2, p15-23. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
